Inhibition of osteoclast differentiation and P. gingivalis lipopolysaccharide-induced alveolar bone resorption by novel Bruton's tyrosine kinase inhibitor acalabrutinib

被引：0
|
作者：
Lee, Youngkyun [1 ]
Kim, Yong-Gun [1 ]
Ha, Jung-Hong [1 ]
机构：
[1] Kyungpook Natl Univ, Sch Dent, Daegu, South Korea
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0612
引用
收藏
页码：160 / 160
页数：1
相关论文
共 42 条
  • [1] A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption
    Pokhrel, Nitin Kumar
    Kim, Yong-Gun
    Kim, Hyo Jeong
    Kim, Hyung Joon
    Lee, Ji Hye
    Choi, So-Young
    Kwon, Tae-Geon
    Lee, Heon-Jin
    Kim, Jae-Young
    Lee, Youngkyun
    JOURNAL OF PERIODONTOLOGY, 2019, 90 (05) : 546 - 554
  • [2] Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice
    Pokhrel, Nitin Kumar
    Kim, Yong-Gun
    Kim, Jae-Young
    Kim, Hong-Hee
    Lee, Youngkyun
    JOURNAL OF PERIODONTOLOGY, 2017, 88 (04) : 390 - 398
  • [3] Bortezomib Inhibits Osteoclastogenesis and Porphyromonas gingivalis Lipopolysaccharide-induced Alveolar Bone Resorption
    Kim, Y. -G.
    Kang, J. H.
    Kim, H. J.
    Kim, H. J.
    Kim, H. -H.
    Kim, J. -Y.
    Lee, Y.
    JOURNAL OF DENTAL RESEARCH, 2015, 94 (09) : 1243 - 1250
  • [4] Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage
    Shaker, Mohamed E.
    Gomaa, Hesham A. M.
    Alharbi, Khalid S.
    Al-Sanea, Mohammad M.
    El-Mesery, Mohamed E.
    Hazem, Sara H.
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [5] Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-B Kinase Activity
    Hirata, Narumi
    Ichimaru, Ryota
    Tominari, Tsukasa
    Matsumoto, Chiho
    Watanabe, Kenta
    Taniguchi, Keita
    Hirata, Michiko
    Ma, Sihui
    Suzuki, Katsuhiko
    Grundler, Florian M. W.
    Miyaura, Chisato
    Inada, Masaki
    NUTRIENTS, 2019, 11 (02):
  • [6] Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
    Ariza, Yuko
    Murata, Masayuki
    Ueda, Yoshiko
    Yoshizawa, Toshio
    BONE REPORTS, 2019, 10
  • [7] DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo
    Ishida, Masahiko
    Shen, Wei-Ren
    Kimura, Keisuke
    Kishikawa, Akiko
    Shima, Kazuhiro
    Ogawa, Saika
    Qi, Jiawei
    Ohori, Fumitoshi
    Noguchi, Takahiro
    Marahleh, Aseel
    Kitaura, Hideki
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 242 - 253
  • [8] Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor at production
    Horwood, NJ
    Mahon, T
    McDaid, JP
    Campbell, J
    Mano, H
    Brennan, FM
    Webster, D
    Foxwell, BMJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12): : 1603 - 1611
  • [9] Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors
    Stralberg, Fredrik
    Kassem, Ali
    Kasprzykowski, Franciszek
    Abrahamson, Magnus
    Grubb, Anders
    Lindholm, Catharina
    Lerner, Ulf H.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 101 (05) : 1233 - 1243
  • [10] Inhibitory effects of Jixueteng on P. gingivalis-induced bone loss and osteoclast differentiation
    Toyama, Toshizo
    Todoki, Kazuo
    Takahashi, Yusuke
    Watanabe, Kiyoko
    Takahashi, Shun-suke
    Sugiyama, Shuta
    Lee, Masaichi-Chang-il
    Hamada, Nobushiro
    ARCHIVES OF ORAL BIOLOGY, 2012, 57 (11) : 1529 - 1536
12345